These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma. Lynch KT; Young SJ; Meneveau MO; Wages NA; Engelhard VH; Slingluff CL; Mauldin IS J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34103353 [TBL] [Abstract][Full Text] [Related]
3. Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma. Sayour EJ; McLendon P; McLendon R; De Leon G; Reynolds R; Kresak J; Sampson JH; Mitchell DA Cancer Immunol Immunother; 2015 Apr; 64(4):419-27. PubMed ID: 25555571 [TBL] [Abstract][Full Text] [Related]
4. Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer. Wessel RE; Ageeb N; Obeid JM; Mauldin IS; Goundry KA; Hanson GF; Hossain M; Lehman C; Gentzler RD; Wages NA; Slingluff CL; Bullock TNJ; Dolatshahi S; Brown MG J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39299754 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas. Donizy P; Wu CL; Kopczynski J; Pieniazek M; Biecek P; Ryś J; Hoang MP Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071045 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer. Kinoshita T; Muramatsu R; Fujita T; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Kudo-Saito C; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H; Kawakami Y Ann Oncol; 2016 Nov; 27(11):2117-2123. PubMed ID: 27502728 [TBL] [Abstract][Full Text] [Related]
7. Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8 Park J; Kwon M; Kim KH; Kim TS; Hong SH; Kim CG; Kang SG; Moon JH; Kim EH; Park SH; Chang JH; Shin EC Clin Cancer Res; 2019 Apr; 25(8):2549-2559. PubMed ID: 30659023 [TBL] [Abstract][Full Text] [Related]
8. Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome. González-Tablas Pimenta M; Otero Á; Arandia Guzman DA; Pascual-Argente D; Ruíz Martín L; Sousa-Casasnovas P; García-Martin A; Roa Montes de Oca JC; Villaseñor-Ledezma J; Torres Carretero L; Almeida M; Ortiz J; Nieto A; Orfao A; Tabernero MD Brain Pathol; 2021 Mar; 31(2):365-380. PubMed ID: 33314398 [TBL] [Abstract][Full Text] [Related]
9. Analysis of immunobiologic markers in primary and recurrent glioblastoma. Rahman M; Kresak J; Yang C; Huang J; Hiser W; Kubilis P; Mitchell D J Neurooncol; 2018 Apr; 137(2):249-257. PubMed ID: 29302887 [TBL] [Abstract][Full Text] [Related]
10. The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw. Innocenti L; Ortenzi V; Scarpitta R; Montemurro N; Pasqualetti F; Asseri R; Lazzi S; Szumera-Cieckiewicz A; De Ieso K; Perrini P; Naccarato AG; Scatena C; Fanelli GN Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833428 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Relevance of the Relative Presence of CD4, CD8 and CD20 Expressing Tumor Infiltrating Lymphocytes in Operable Non-small Cell Lung Cancer Patients. Giatromanolaki A; Anestopoulos I; Panayiotidis MI; Mitrakas A; Pappa A; Koukourakis MI Anticancer Res; 2021 Aug; 41(8):3989-3995. PubMed ID: 34281863 [TBL] [Abstract][Full Text] [Related]
12. Aging- and Tumor-Mediated Increase in CD8 Huff WX; Bam M; Shireman JM; Kwon JH; Song L; Newman S; Cohen-Gadol AA; Shapiro S; Jones T; Fulton K; Liu S; Tanaka H; Liu Y; Wan J; Dey M Immunohorizons; 2021 Jun; 5(6):395-409. PubMed ID: 34103370 [TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8 Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665 [TBL] [Abstract][Full Text] [Related]
14. Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme. Jan CI; Tsai WC; Harn HJ; Shyu WC; Liu MC; Lu HM; Chiu SC; Cho DY Front Immunol; 2018; 9():727. PubMed ID: 29910795 [TBL] [Abstract][Full Text] [Related]
15. Impact of Multifocality and Molecular Markers on Survival of Glioblastoma. Ahmadipour Y; Jabbarli R; Gembruch O; Pierscianek D; Darkwah Oppong M; Dammann P; Wrede K; Özkan N; Müller O; Sure U; El Hindy N World Neurosurg; 2019 Feb; 122():e461-e466. PubMed ID: 30347300 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium. Bachmayr-Heyda A; Aust S; Heinze G; Polterauer S; Grimm C; Braicu EI; Sehouli J; Lambrechts S; Vergote I; Mahner S; Pils D; Schuster E; Thalhammer T; Horvat R; Denkert C; Zeillinger R; Castillo-Tong DC BMC Cancer; 2013 Sep; 13():422. PubMed ID: 24044611 [TBL] [Abstract][Full Text] [Related]
17. Immune involvement of the contralateral hemisphere in a glioblastoma mouse model. Crommentuijn MHW; Schetters STT; Dusoswa SA; Kruijssen LJW; Garcia-Vallejo JJ; van Kooyk Y J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303613 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma. Yue Q; Zhang X; Ye HX; Wang Y; Du ZG; Yao Y; Mao Y J Neurooncol; 2014 Jan; 116(2):251-9. PubMed ID: 24276989 [TBL] [Abstract][Full Text] [Related]
19. T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma. Woroniecka K; Chongsathidkiet P; Rhodin K; Kemeny H; Dechant C; Farber SH; Elsamadicy AA; Cui X; Koyama S; Jackson C; Hansen LJ; Johanns TM; Sanchez-Perez L; Chandramohan V; Yu YA; Bigner DD; Giles A; Healy P; Dranoff G; Weinhold KJ; Dunn GP; Fecci PE Clin Cancer Res; 2018 Sep; 24(17):4175-4186. PubMed ID: 29437767 [No Abstract] [Full Text] [Related]